← Evidence map

ReviewMolecular carcinogenesis2023

The action and resistance mechanisms of Lenvatinib in liver cancer.

Anna Buttell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

27 papers cite it

2023
2024
2025
2026
this papercites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 37671815